New

Thalidomide Babies: A Resilient Generation’s Untold Progress

Thalidomide first entered the market in the 1950s, developed by the German pharmaceutical company Chemie Grünenthal. It caused one of the most devastating medical scandals due to birth defects in babies, leading to enhanced drug regulations globally.